预览加载中，请您耐心等待几秒...

核医学nuclearmedicine-ppt课件.ppt

预览
1/10
2/10
3/10
4/10
5/10
6/10
7/10
8/10
9/10
10/10

亲，该文档总共72页，到这已经超出免费预览范围，如果喜欢就直接下载吧～

下载提示 文本预览

如果您无法下载资料，请参考说明：

1、部分资料下载需要金币，请确保您的账户上有足够的金币

2、已购买过的文档，再次下载不重复扣费

3、资料包下载后请先用软件解压，在使用对应软件打开

NuclearMedicineFisson/ReactorProducts CyclotronProductsDefinitionofRadiopharmaceuticalIdealRadiopharmaceuticalforImaging-FactorstoConsiderIdealPhysicalCharacteristicsofImagingRadiopharmaceuticalRadioactiveDecayProcessesDiagnosticNuclearMedicineAnatomicvs.PhysiologicImagingHowdoesPhysiologicImagingWork?Anatomyvs.PhysiologyGammaCameraGammaCameraConsistsof…SodiumIodideDetectorSodiumIodideDetector,cont’d...CollimatorGammaCameraBasics*GEWholeBodyGammaCameraSPECTImagingMo-99/Tc-99mGeneratorColumnChromatographyCardiacInfarction 201TlClRest 99mTc-Sestamibi StressTestCardiacIschemia 201TlClRest 99mTc-Sestamibi StressTest(MDP)NormalCanineBoneScanRibMetastasis11-yearoldboywithaone monthhistoryofrightknee pain Increaseactivityintheright tibia Diagnosis:OsteosarcomaMetastaticProstateCarcinoma Imaging 99mTc-HDPPrincipleofPETImaging[18F]Fluorodeoxyglucose(FDG)PETTherapeuticNuclearMedicineFissionproductsusefulinnuclearmedicineinclude: 99Mo,131I,133Xe,137Csand90SrDifferentiated Thyroid Carcinoma 5mCiNa131I Imaging TreatmentPlanning 48hp.i.Differentiated Thyroid Carcinoma Therapy 105mCiNa131I 27hp.i.DifferentiatedThyroidCarcinoma PostSurgicalResection Therapy 57CoFloodSource+105mCiNa131IDifferentiatedThyroidCarcinoma 201TlCland99mTc-SestamibiImaging 4monthsafterNa131ITherapyCanineOsteosarcomaStoryofQuadraMetTM--IOneofOurFirstPatientsBoneScansofCaninePatientResultsofClinicalTrialof153Sm-EDTMPinCanineOsteosarcomaStoryofQuadraMet™--II153Sm-EDTMP[QuadraMet]ExperimentalNuclearMedicineTargetingvector(e.g.,mAb,peptidehormone,smallmolecule,etc.) Radionuclide(e.g.,diagnostic–99mTc,111In,etc.;therapeutic–188Re,90Y,177Lu,etc.) Bifunctionalchelatingagent(BCA) Linkerorspacer Hypothesis1ReceptorTargetingforMolecularImagingandTherapyInternalizingvs.Non-internalizingReceptorsPeptideNucleicAcidCellularDeliveryofPNADOTA-Tyr3-OctreotatePNAandPeptideConjugatesMicroSPECT/CTUsing111In-labeledPNAandPeptideConjugates(1h,48h)Bcl-2mRNAExpressionLevelsinMec-1andRamosCellsMicroSPECT/CTUsing111In-DOT